Carmell (CTCX) Competitors $0.47 -0.05 (-9.90%) Closing price 04:00 PM EasternExtended Trading$0.48 +0.00 (+0.59%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends CTCX vs. CLGN, MODD, OM, DXR, MDAI, MBOT, NMTC, NXL, COCH, and SURGShould you be buying Carmell stock or one of its competitors? The main competitors of Carmell include CollPlant Biotechnologies (CLGN), Modular Medical (MODD), Outset Medical (OM), Daxor (DXR), Spectral AI (MDAI), Microbot Medical (MBOT), NeuroOne Medical Technologies (NMTC), Nexalin Technology (NXL), Envoy Medical (COCH), and SurgePays (SURG). These companies are all part of the "medical equipment" industry. Carmell vs. CollPlant Biotechnologies Modular Medical Outset Medical Daxor Spectral AI Microbot Medical NeuroOne Medical Technologies Nexalin Technology Envoy Medical SurgePays Carmell (NASDAQ:CTCX) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, community ranking, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings. Which has preferable earnings & valuation, CTCX or CLGN? CollPlant Biotechnologies has higher revenue and earnings than Carmell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCarmellN/AN/A-$15.44MN/AN/ACollPlant Biotechnologies$10.96M4.25-$7.02M-$1.54-2.64 Which has more risk and volatility, CTCX or CLGN? Carmell has a beta of 0.3, indicating that its share price is 70% less volatile than the S&P 500. Comparatively, CollPlant Biotechnologies has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500. Do insiders & institutionals believe in CTCX or CLGN? 24.2% of Carmell shares are held by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are held by institutional investors. 29.0% of Carmell shares are held by company insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media favor CTCX or CLGN? In the previous week, Carmell had 2 more articles in the media than CollPlant Biotechnologies. MarketBeat recorded 2 mentions for Carmell and 0 mentions for CollPlant Biotechnologies. Carmell's average media sentiment score of -0.33 beat CollPlant Biotechnologies' score of -1.00 indicating that Carmell is being referred to more favorably in the media. Company Overall Sentiment Carmell Neutral CollPlant Biotechnologies Negative Is CTCX or CLGN more profitable? Carmell has a net margin of 0.00% compared to CollPlant Biotechnologies' net margin of -2,680.00%. CollPlant Biotechnologies' return on equity of -77.05% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets CarmellN/A -217.50% -50.22% CollPlant Biotechnologies -2,680.00%-77.05%-61.43% Do analysts recommend CTCX or CLGN? CollPlant Biotechnologies has a consensus target price of $12.50, indicating a potential upside of 207.13%. Given CollPlant Biotechnologies' stronger consensus rating and higher probable upside, analysts clearly believe CollPlant Biotechnologies is more favorable than Carmell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Carmell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00CollPlant Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Does the MarketBeat Community believe in CTCX or CLGN? CollPlant Biotechnologies received 138 more outperform votes than Carmell when rated by MarketBeat users. CompanyUnderperformOutperformCarmellN/AN/ACollPlant BiotechnologiesOutperform Votes13859.48% Underperform Votes9440.52% SummaryCollPlant Biotechnologies beats Carmell on 9 of the 15 factors compared between the two stocks. Get Carmell News Delivered to You Automatically Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTCX vs. The Competition Export to ExcelMetricCarmellSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.39M$4.83B$5.39B$9.14BDividend YieldN/A52.58%5.37%4.00%P/E RatioN/A26.1388.1017.53Price / SalesN/A61.291,285.4080.11Price / CashN/A50.8936.6032.90Price / Book0.467.894.954.67Net Income-$15.44M$13.87M$117.96M$224.69M7 Day Performance-20.12%4.06%2.49%3.32%1 Month Performance123.23%11.17%3.44%5.36%1 Year Performance-84.72%33.28%27.06%22.59% Carmell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTCXCarmell0.4285 of 5 stars$0.47-9.9%N/A-83.7%$9.90MN/A0.0014CLGNCollPlant Biotechnologies2.1003 of 5 stars$3.93-6.4%$12.50+218.1%-24.0%$45.02M$650,000.00-2.5570Positive NewsMODDModular Medical2.4122 of 5 stars$1.26-4.5%$5.00+296.8%-32.4%$43.71MN/A-2.0020Positive NewsOMOutset Medical3.0175 of 5 stars$0.81-12.2%$4.50+457.1%-78.1%$42.44M$114.73M-0.29520DXRDaxor3.1012 of 5 stars$8.25+0.4%$24.75+200.0%-14.6%$39.77M$2.61M0.0037Short Interest ↑MDAISpectral AI2.2414 of 5 stars$2.01-8.6%$4.50+123.9%-3.9%$37.36M$27.26M-3.0983Gap DownMBOTMicrobot Medical2.7027 of 5 stars$1.78-7.8%$7.00+293.3%+22.4%$36.03MN/A-2.2220News CoverageGap UpNMTCNeuroOne Medical Technologies0.5145 of 5 stars$1.12-1.0%N/A-23.4%$34.54M$3.45M-2.3320NXLNexalin Technology0.8817 of 5 stars$2.51-5.6%$3.00+19.5%+605.5%$33.39M$162,078.00-3.923COCHEnvoy Medical2.3491 of 5 stars$1.58+7.7%$8.00+405.4%+4.7%$32.04M$278,000.000.0034SURGSurgePays3.2768 of 5 stars$1.58-6.0%$8.50+438.0%-75.2%$31.86M$83.60M-1.4040News CoveragePositive News Related Companies and Tools Related Companies CLGN Alternatives MODD Alternatives OM Alternatives DXR Alternatives MDAI Alternatives MBOT Alternatives NMTC Alternatives NXL Alternatives COCH Alternatives SURG Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CTCX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carmell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carmell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTCX Stock Alerts